Abstract:RACK1 was upregulated in cervical cancer and its expression was positively correlated with tumor grading. RACK1 overexpression of RACK1 enhanced tumor formation and growth in an orthotopic nude mouse model. For mechanism, RACK1 functions as a cell cycle regulator by modulating the phosphorylation of AKT. Targeting RACK1 may be a promising method for CC therapy. Background RACK1 has been identified as a multifunctional cytosolic protein, and plays a pivotal role in multiple biological responses involved in several kinds of tumors, while its effect in cervical cancer has not been well elucidated yet. The study aimed to investigate the role of RACK1 in cervical cancer occurrence and progression. Methods The expression of RACK1 in cervical specimens was measured by immunohistochemical staining and Western blot assay. Transgenic mice were used to detect the role of RACK1 in modulating tumorigenesis in vivo. Cervical carcinoma cell lines were used to explore the underlying mechanisms of RACK1 on the behaviors of tumor cells in vitro. Results We found that RACK1 expression was upregulated in cancer tissues compared with adjacent tissues, and its expression was gradually increased from cervictis, and cervical intraepithelial neoplasis (CIN) to carcinoma. Genetic overexpression of RACK1 facilitated tumor formation and growth in nude mice. Mechanism studies disclosed that RACK1 over‐expression prolonged the G0/G1 phase by up‐regulating the expression of cyclinD1, down‐regulating p21 and p27 probably by modulating the phosphorylation of AKT. Conclusions Taken together, we concluded that RACK1 stimulates tumorigenesis and progression of cervical cancer via modulating the proliferation of tumor cells, implying that targeting RACK1 may serve as a promising method for cervical cancer therapy.

RACK1 associates with CLEC-2 and promotes its ubiquitin-proteasome degradation.

RACK1, Scaffolding a Heterotrimeric G Protein and a MAPK Cascade.

Receptor for Activated C Kinase 1 (RACK1) Promotes Dishevelled Protein Degradation via Autophagy and Antagonizes Wnt Signaling

RACK1 facilitates breast cancer progression by competitively inhibiting the binding of β-catenin to PSMD2 and enhancing the stability of β-catenin

Advances on the Study of CLEC-2, a New C-type Lectin Receptor

Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets

RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1

RACK1 promotes Bax oligomerization and dissociates the interaction of Bax and Bcl-XL

The research progress of calcium-dependent lectin-like receptor 2(CLEC-2)

E3 Ubiquitin Ligase CHIP Interacts with C-type Lectin-Like Receptor CLEC-2 and Promotes Its Ubiquitin-Proteasome Degradation.

RACK1 Promotes the Proliferation of THP1 Acute Myeloid Leukemia Cells

RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation

RACK1 modulates polyglutamine-induced neurodegeneration by promoting ERK degradation in Drosophila

The Production of Soluble C-type Lectin-Like Receptor 2 is a Regulated Process

RACK1 to Modulate Expression of MMP10 Via Src/NF-κB Pathway in Gastric Cancer.

Structural and Functional Conservation of CLEC-2 with the Species-Specific Regulation of Transcript Expression in Evolution

RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo

RACK1 promotes porcine reproductive and respiratory syndrome virus infection in Marc-145 cells through ERK1/2 activation

RACK1 Competes with HSP90 for Binding to HIF-1α and Is Required for O2-Independent and HSP90 Inhibitor-Induced Degradation of HIF-1α

RACK1 Silencing Attenuates Renal Fibrosis by Inhibiting TGF-β Signaling.

RACK1 promotes the occurrence and progression of cervical carcinoma